Federal Healthcare Fraud — federal defense framework

Section 1347 — elements and statutory framework

Section 1347 makes it a crime to "knowingly and willfully execute, or attempt to execute, a scheme or artifice (1) to defraud any health care benefit program, or (2) to obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any health care benefit program, in connection with the delivery of or payment for health care benefits, items, or services."

"Health care benefit program" is defined at 18 U.S.C. § 24(b) to include "any public or private plan or contract, affecting commerce, under which any medical benefit, item, or service is provided to any individual." Medicare, Medicaid, TRICARE, the Federal Employees Health Benefits Program, and most private commercial insurance fall within the definition.

The Fifth Circuit pattern jury instructions break § 1347 into three elements: (1) the defendant knowingly and willfully executed, or attempted to execute, a scheme or artifice to defraud a health-care benefit program or to obtain money or property by false pretenses; (2) the scheme was in connection with the delivery of or payment for healthcare benefits, items, or services; and (3) the defendant acted with intent to defraud. See United States v. Mauskar, 557 F.3d 219 (5th Cir. 2009); United States v. Mahmood, 820 F.3d 177 (5th Cir. 2016).

Each separate "execution" of the scheme — typically each fraudulent claim submitted to Medicare or Medicaid — is a separate count. United States v. Hickman, 331 F.3d 439, 446 (5th Cir. 2003) (en banc) (§ 1347 "punishes executions or attempted executions of schemes to defraud, ... not simply acts in furtherance of the scheme"). A six-month billing pattern producing 200 fraudulent claims typically produces a multi-count indictment.

The Anti-Kickback Statute — 42 U.S.C. § 1320a-7b

The Anti-Kickback Statute (AKS), 42 U.S.C. § 1320a-7b(b), makes it a felony to "knowingly and willfully" solicit, receive, offer, or pay "any remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in kind" in return for referring an individual for, or arranging for, an item or service for which payment may be made by a federal health-care program. The statute carries a 10-year statutory maximum and a $100,000 fine per violation.

Five elements must be proved beyond a reasonable doubt: (1) the defendant solicited, received, offered, or paid remuneration; (2) directly or indirectly; (3) to induce a referral; (4) the item or service was payable by a federal health-care program; and (5) the defendant acted knowingly and willfully. See United States v. St. Junius, 739 F.3d 193 (5th Cir. 2013). "Remuneration" is construed broadly; courts have held that anything of value — including free office space, marketing services, equipment loans, or speaking fees — may constitute remuneration depending on intent.

The Fifth Circuit applies the "one purpose" test: if even one purpose of a payment was to induce referrals, the AKS is violated, even if other legitimate purposes also existed. The defense battles are usually fought on the "knowingly and willfully" element — particularly post-Cheek v. United States, 498 U.S. 192 (1991), which holds that "willfully" requires a voluntary intentional violation of a known legal duty.

The 2010 Affordable Care Act amended the AKS at 42 U.S.C. § 1320a-7b(g) to provide that "a claim that includes items or services resulting from a violation of [the AKS] constitutes a false or fraudulent claim" under the False Claims Act. The amendment effectively automated parallel FCA exposure for AKS-violating claims and made every AKS-based prosecution simultaneously a False Claims Act civil exposure for the defendant.

Safe harbors at 42 C.F.R. § 1001.952 protect specific payment arrangements — investment interests, space rental, equipment rental, personal services and management contracts, sale of a practice, referral services, warranties, discounts, and others. Compliance with a safe harbor is voluntary and constitutes an absolute defense; non-compliance does not by itself prove a violation, but it removes a layer of protection.

Ruan v. United States — subjective mens rea for prescribing

Many federal healthcare-fraud cases against physicians and mid-level providers proceed in parallel with charges under the Controlled Substances Act, 21 U.S.C. § 841, for unauthorized distribution of controlled substances by prescription. Ruan v. United States, 597 U.S. 450 (2022), fundamentally reshaped the mens-rea requirement for those prosecutions.

Section 841 makes it unlawful, "except as authorized," to "knowingly or intentionally" manufacture, distribute, or dispense a controlled substance. Regulations at 21 C.F.R. § 1306.04(a) provide that a prescription is "authorized" if it is "issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice." Before Ruan, most circuits applied an objective standard — whether the prescription was outside the usual course of professional practice as a reasonable physician would understand it.

Ruan rejected the objective approach. The Court held: "Section 841's 'knowingly or intentionally' mens rea applies to the statute's 'except as authorized' clause. Once a defendant meets the burden of producing evidence that his or her conduct was 'authorized,' the Government must prove beyond a reasonable doubt that the defendant knowingly or intentionally acted in an unauthorized manner." Ruan, 597 U.S. at 454. The defendant must produce some evidence of authorization; the government must then prove beyond a reasonable doubt that the defendant knew the prescription was outside the usual course of practice.

The Court was careful to note that the subjective mens-rea standard does not insulate physicians: "the more unreasonable" a defendant's asserted beliefs are, "especially as measured against objective criteria, the more likely the jury . . . will find that the Government has carried its burden of proving knowledge." Ruan, 597 U.S. at 467 (quoting Cheek v. United States, 498 U.S. 192, 203-04 (1991)).

In practice, Ruan has reshaped indictment review and trial strategy in physician-distribution and pill-mill cases. Defense practice involves: (a) front-loading evidence of authorization — the prescribing standard, the physician's training, the patient's documented history, the physical exam findings, and the clinical justification — to satisfy the defendant's burden of production; (b) cross-examining the government's expert physician-witness to confirm that legitimate clinical disagreement exists; and (c) ensuring the jury instructions accurately reflect Ruan's subjective-mens-rea framework.

Parallel exposure — False Claims Act and Stark Law

Most federal criminal healthcare-fraud prosecutions originate as False Claims Act qui tam cases. The False Claims Act, 31 U.S.C. § 3729, allows private relators ("whistleblowers") to file sealed civil complaints on behalf of the United States and to share in any recovery. The government investigates under seal — often for years — and decides whether to intervene. Where the evidence indicates criminal conduct, the United States Attorney's Office for the relevant district may file parallel criminal charges.

Universal Health Services, Inc. v. United States ex rel. Escobar, 579 U.S. 176 (2016), confirmed that "implied certification" can serve as a basis for FCA liability where a claim makes specific representations about goods or services provided but fails to disclose noncompliance with material statutory, regulatory, or contractual requirements. Materiality is "demanding": the misrepresentation must be material to the government's payment decision.

United States ex rel. Schutte v. Supervalu Inc., 598 U.S. ___ (2023), addressed the FCA's "knowing" element. The Court held that the FCA's scienter element refers to the defendant's subjective knowledge — not what an objectively reasonable defendant might have known. A defendant's subjective belief in the legitimacy of its conduct matters; a post-hoc objectively-reasonable interpretation does not insulate the defendant from FCA liability if the defendant subjectively believed otherwise.

The Stark Law, 42 U.S.C. § 1395nn, is a strict-liability civil prohibition against physician self-referrals to entities with which the physician has a financial relationship. Unlike the AKS, Stark requires no intent. Stark violations create FCA exposure for any Medicare claims submitted in connection with prohibited self-referrals.

The 2010 ACA, 42 U.S.C. § 1320a-7k(d), imposes a 60-day overpayment return obligation: once a Medicare or Medicaid provider identifies an overpayment, the provider must report and return it within 60 days. Failure to do so creates additional FCA exposure under the "reverse false claims" theory of 31 U.S.C. § 3729(a)(1)(G).

Common predicate offenses — wire fraud, money laundering, identity theft

Federal healthcare-fraud indictments rarely stand alone. The AUSA almost always pairs § 1347 with overlapping counts.

• Conspiracy under 18 U.S.C. § 1349 — same statutory maximum as the object offense; no overt-act requirement.
• Mail and wire fraud — §§ 1341 and 1343 — where claims were submitted electronically (which they almost always are) or where payment was received by EFT, the wire-fraud statute reaches the same conduct. The 20-year statutory maximum on §§ 1341 and 1343 exceeds the 10-year maximum on § 1347, which matters at sentencing if the government wants headroom for an upward variance.
• Money laundering — 18 U.S.C. §§ 1956 and 1957 — where the proceeds of the fraud were moved through bank accounts. Section 1956 (promotional and concealment laundering) carries a 20-year statutory maximum; § 1957 (monetary transactions over $10,000 in criminally derived property) carries 10 years. These counts also drive forfeiture exposure.
• Aggravated identity theft — 18 U.S.C. § 1028A — a mandatory consecutive two-year sentence where the defendant used "a means of identification of another person" during and in relation to a predicate fraud felony. Dubin v. United States, 599 U.S. 110 (2023), narrowed § 1028A: the use of identification must be "at the crux" of the criminality, not merely an ancillary feature of a fraudulent claim. Billing using a patient's actual identity for unauthorized services may not qualify; impersonating someone to obtain unauthorized credentials or to bill in another's name does.
• Obstruction — 18 U.S.C. § 1518 — obstructing a federal health-care fraud investigation; five-year statutory maximum. Pairs with general obstruction under § 1512 (witness tampering) and § 1519 (destruction of records).

USSG § 2B1.1 loss calculation in healthcare-fraud cases

Federal healthcare-fraud sentencing proceeds under United States Sentencing Guidelines § 2B1.1. The base offense level is 6 (7 because § 1347 carries a 20-year maximum when serious bodily injury results, and §§ 1341 and 1343 always carry 20-year maximums). The loss-enhancement table at § 2B1.1(b)(1) adds offense levels in increments tied to dollar loss.

Loss in healthcare-fraud cases is typically measured by the amount Medicare or Medicaid actually paid (or in some circuits would have paid) on fraudulent claims. The government usually introduces summary claims data from the relevant CMS contractor and an expert witness — often a Medicare Program Integrity Contractor analyst — to quantify the loss. Defense practice involves heavy litigation over: (a) which specific claims should be deemed fraudulent and which were legitimate; (b) whether the "intended loss" measure under § 2B1.1 app. note 3 properly applies where the government argues a larger billed but lower paid amount; and (c) what credit the defendant gets for medically necessary services actually provided (§ 2B1.1 app. note 3(E)).

Specific offense characteristics commonly added in healthcare cases include: § 2B1.1(b)(2) (number of victims, particularly where individual patients are treated as victims in addition to Medicare or Medicaid); § 2B1.1(b)(7) (federal health-care offense with loss to government of more than $1 million: +2 levels; more than $7 million: +3; more than $20 million: +4); § 2B1.1(b)(10) (sophisticated means: +2); and Chapter Three role-in-the-offense adjustments. Subsection (b)(7) makes federal health-care fraud one of the few § 2B1.1 offenses with a built-in additional enhancement on top of the general loss table.

After the guidelines calculation, the court must consider the factors at 18 U.S.C. § 3553(a). Variances downward in healthcare-fraud cases — particularly where the loss table overstates the seriousness of the offense, where the defendant provided medically necessary services that were correctly billed alongside the fraudulent ones, or where collateral consequences (professional license revocation, exclusion from federal health-care programs under 42 U.S.C. § 1320a-7) substantially exceed the criminal sentence — are increasingly common.

Pretrial detention, restitution, exclusion, and forfeiture

Pretrial detention in healthcare-fraud cases is uncommon. The Bail Reform Act at 18 U.S.C. § 3142 does not trigger automatic detention for § 1347 or AKS offenses. The typical posture is release on an unsecured or property bond with conditions limited to travel restrictions, passport surrender, and pretrial supervision check-ins. Where the AUSA argues for detention, the argument typically rests on flight risk (particularly where the defendant holds substantial assets abroad) or on a showing that continued practice would pose a danger to patients.

Restitution is mandatory under the Mandatory Victims Restitution Act, 18 U.S.C. § 3663A. The restitution amount is fixed by the court at sentencing based on actual loss to identifiable victims — Medicare, Medicaid, TRICARE, and any private payers — by a preponderance of the evidence. The order survives bankruptcy discharge.

Mandatory exclusion under 42 U.S.C. § 1320a-7(a)(1) follows automatically from a criminal conviction "related to the delivery of an item or service" under Medicare or a state health-care program. The minimum exclusion period is five years; longer periods apply where aggravating factors are present. Exclusion bars the defendant from receiving any federal health-care program reimbursement and effectively ends a clinical practice. The collateral consequence often dwarfs the criminal sentence in practical impact.

Forfeiture proceeds under 18 U.S.C. § 982(a)(7), which authorizes criminal forfeiture of property "constituting or derived, directly or indirectly, from gross proceeds traceable to the commission of" a federal health-care offense. Honeycutt v. United States, 581 U.S. 443 (2017), limits forfeiture to property the defendant personally acquired, foreclosing joint-and-several liability for co-conspirator proceeds.

Defense strategy and 5th Circuit healthcare-fraud practice

Healthcare-fraud cases are document-heavy, expert-intensive, and fact-specific. Defense practice in TXND and TXED healthcare-fraud cases focuses on the following angles:

• Lack of intent / good-faith defense — the defendant believed in good faith that the services billed were medically necessary and properly coded. Where a billing staff member or third-party biller made the actual coding decisions, the defendant's knowledge of fraudulent claims is the central battle.
• Medical-necessity dispute — the services billed were medically appropriate based on the standard of care; the government's expert disagrees, but reasonable physicians might differ. This is the central battleground in most provider cases.
• Ruan subjective mens rea — in physician-distribution cases under § 841, the defendant produced evidence of authorization, and the government has not proved that the defendant subjectively knew the prescription was outside the usual course of practice.
• AKS safe-harbor / "one purpose" defense — the payment arrangement falls within a 42 C.F.R. § 1001.952 safe harbor; or, where no safe harbor applies, the dominant purpose of the payment was a legitimate one and the government has not proved that "one purpose" was to induce referrals.
• Loss-calculation challenge — the government's loss methodology overstates actual loss; the defendant deserves credit for medically necessary services actually delivered; intended-loss measure is improper.
• Statute of limitations — the default federal limitations period under 18 U.S.C. § 3282 is five years. Where the scheme spans years, the limitations cutoff trims counts.
• Reverse proffer and pre-indictment resolution — in many provider cases, particularly those originating as qui tam complaints, pre-indictment engagement with the AUSA can produce a civil-only resolution under the FCA, sometimes coupled with a deferred-prosecution agreement or non-prosecution agreement on the criminal side.

Investigations are typically led by the FBI, HHS-OIG, and the Medicare Strike Force units that operate out of the U.S. Attorney's Office. The Strike Force model — first deployed in South Florida and now active in DFW — produces high-volume, data-driven prosecutions targeting billing anomalies identified through CMS claims-data analysis. Defense work in a Strike Force case requires rapid response to grand-jury subpoenas, careful privilege review, and early engagement with the prosecution to surface defenses before the indictment is returned.